REGENPEP
Live / Applied — Second extension granted (statement of use) (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 24 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98567742
- Mark type
- Stylized text
- Filed
- 24 May 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Michael J. Hertz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, preparations for the treatment of diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases, and other diseases requiring both cellular regenerative activity and suppression of autoimmunity
Owner
- IsletRegen, LLC, Charlottesville, VA, US
- IsletRegen, LLC, Charlottesville, VA, US
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 2 GRANTED
- 03 Mar 2026 — SOU EXTENSION 2 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Aug 2025 — SOU EXTENSION 1 GRANTED
- 29 Aug 2025 — SOU EXTENSION 1 FILED
- 29 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Dec 2024 — ASSIGNED TO EXAMINER
- 13 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED